Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-02-27FDA Approved: BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Budesonide and Formoterol Fumarate Dihydrate (Symbicort) by AstraZeneca Pharmaceuticals LP, …
-
FDA approval · 2008-12-16FDA Approved: ALBUTEROL SULFATE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved Mylan Pharmaceuticals' original application for ALBUTEROL SULFATE as a generic product. Albuterol sulfate is a bronchodilator i…
-
FDA approval · 2008-11-13FDA Approved: SPIRIVA HANDIHALER — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Spiriva HandiHaler (tiotropium bromide) submitted by Boehringer Ingelheim Pharmaceuticals, Inc.
-
FDA approval · 2008-10-14FDA Approved: ATROVENT HFA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for ATROVENT HFA (ipratropium bromide) filed by Boehringer Ingelheim Pharmaceuticals, Inc.
-
FDA approval · 2008-10-10FDA Approved: ALVESCO — Supplemental Application (Covis Pharma US, Inc)
The FDA approved Covis Pharma US's supplemental application for Alvesco (ciclesonide), resulting in changes to the product labeling.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-09-16FDA Approved: IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE — Supplemental Application (Nephron Pharmaceuticals Corporation)
The FDA approved a supplemental application for Nephron Pharmaceuticals Corporation's Ipratropium Bromide and Albuterol Sulfate product.
-
FDA approval · 2008-09-16FDA Approved: ALBUTEROL SULFATE HFA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for ALBUTEROL SULFATE HFA by Teva Pharmaceuticals USA, Inc., updating the product label through a su…
-
FDA approval · 2008-08-27FDA Approved: VENTOLIN HFA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Ventolin HFA (albuterol sulfate) submitted by GlaxoSmithKline LLC. The approval covers the chang…
-
FDA approval · 2008-07-31FDA Approved: ADVAIR HFA — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Advair HFA (fluticasone propionate and salmeterol xinafoate) submitted by GlaxoSmithKline LL…
-
FDA approval · 2008-07-28FDA Approved: PROVOCHOLINE — Supplemental Application (Methapharm Inc.)
FDA approves a supplemental application for PROVOCHOLINE (methacholine chloride inhalation solution) by Methapharm Inc.
-
FDA approval · 2008-07-21FDA Approved: FLUTICASONE PROPIONATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for Fluticasone Propionate, approving an updated or additional ge…
-
FDA approval · 2008-07-16FDA Approved: BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for budesonide and formoterol fumarate dihydrate (Symbicort) from AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2008-06-13FDA Approved: PULMICORT FLEXHALER — Supplemental Application (H2-Pharma LLC)
The FDA approved a supplemental application for Pulmicort Flexhaler (budesonide) submitted by H2-Pharma LLC.
-
FDA approval · 2008-04-24FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Singulair (montelukast sodium) by Organon LLC, updating the product indication/label as part…
-
FDA approval · 2008-04-21FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC.
-
FDA approval · 2008-04-21FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC.
-
FDA approval · 2008-04-11FDA Approved: PULMICORT FLEXHALER — Supplemental Application (H2-Pharma LLC)
FDA approved a supplemental application for Pulmicort Flexhaler (budesonide) submitted by H2-Pharma LLC.
-
FDA approval · 2008-03-20FDA Approved: ADVAIR HFA — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Advair HFA (fluticasone propionate and salmeterol xinafoate) submitted by GlaxoSmithKline, u…
-
FDA approval · 2008-03-20FDA Approved: SEREVENT DISKUS — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for SEREVENT DISKUS (salmeterol xinafoate) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2008-03-07FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) by Organon LLC, updating the product labeling.
-
FDA approval · 2008-03-07FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA approved Organon LLC's supplemental application for Singulair (montelukast), leading to updated labeling for the product. This actio…
-
FDA approval · 2008-03-07FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast) by Organon LLC. The action updates labeling under NDA020829.
-
FDA approval · 2008-02-26FDA Approved: ASMANEX — Supplemental Application (Organon LLC)
FDA approved a supplemental application for ASMANEX (mometasone furoate) submitted by Organon LLC to update the product labeling. The action…
-
FDA approval · 2008-02-05FDA Approved: XOPENEX HFA — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for XOPENEX HFA (levalbuterol tartrate) from Lupin Pharmaceuticals, Inc.
-
FDA approval · 2008-02-01FDA Approved: ASMANEX — Supplemental Application (Organon LLC)
FDA approved a supplemental application for ASMANEX (mometasone furoate) submitted by Organon LLC.